NorthWest Biotherapeutics Inc (NWBO)

[seekinganswers]

RWD can be used if it is in the original trial design and approved by the RAs. NWBO didn't do that.
All the wrong questions though.
NWBO has no money, no marketable product, no sales and marketing team, and has just about exhausted the authorized share limit.
With an MHRA approval, they would have to still run pediatric trials. (big money and will take a very long time). And they would also need NICE to agree to pay for it, which is HIGHLY doubtful.
Without an MHRA approval, they will have to start all over with new INDs for the updated version of DCVax.. Multi hundreds of millions of dollars and many years of waiting and more losses and a falling share price.
Most likely outcome is a 1:40 reverse split to $8-$10 bucks and then many toxic financings that will bring the stock back down to $1 and another 90% loss in PPS.
Company will continue on and shareholders will get wiped out... AGAIN.
JMHO. GL.